| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/28/2009 | US7566774 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 07/28/2009 | US7566772 vector; host cell; inflammatory disorders, arthritis, cachexia and chronic fatigue syndrome, osteoporosis, atherosclerosis, pain related disorders, congestive heart failure, leukemias, multiple myelomas, tumor growth and metastatic spreading. |
| 07/28/2009 | US7566771 Humanised antibodies |
| 07/28/2009 | US7566770 Humanized collagen antibodies and related methods |
| 07/28/2009 | US7566766 Use of phage display libraries in a screening assay in order to determine the identity of peptides sequences which enhance the delivery of the bacteriophage through tissue, such as epithelial cells lining the lumen of gastrointestinal tract |
| 07/28/2009 | US7566764 Truncated BARD1 protein, and its diagnostic and therapeutic uses |
| 07/28/2009 | US7566559 Human cyclin-dependent kinase (hPNQALRE) |
| 07/28/2009 | US7566552 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/28/2009 | US7566549 Using hapten derivatives for the preparation of antigens, antibodies and reagents for use detecting lysergic acid diethylamide (LSD) in samples; hallucinogen |
| 07/28/2009 | US7566541 Diagnostic method for screening complement regulatory protein levels to predict spontaneous abortion |
| 07/28/2009 | US7566540 Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein |
| 07/28/2009 | US7566539 Anti-CCR2 antibodies and methods of use therefor |
| 07/28/2009 | US7566453 Methods for treating melanomas |
| 07/28/2009 | US7566451 Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency |
| 07/28/2009 | US7566450 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders |
| 07/28/2009 | US7566449 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins |
| 07/28/2009 | US7566447 Biocides |
| 07/23/2009 | WO2009092049A1 Improved anti-trkb antibodies |
| 07/23/2009 | WO2009091905A1 Methods of treating bone-loss disorders using a gm-csf antagonist |
| 07/23/2009 | WO2009091826A2 Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car) |
| 07/23/2009 | WO2009091810A1 Methods for inhibiting angiogenesis using egfl8 antagonists |
| 07/23/2009 | WO2009091680A1 High performance liquid chromatographic (hplc) purification of proteins using semi-compressible resins |
| 07/23/2009 | WO2009091601A1 Methods for manipulating phagocytosis mediated by cd47 |
| 07/23/2009 | WO2009091023A1 Composition and method for diagnosis or detection of gastric cancer |
| 07/23/2009 | WO2009090268A1 Peptide mimetics |
| 07/23/2009 | WO2009090032A1 Afucosylated antibodies against ccr5 and their use |
| 07/23/2009 | WO2009089998A1 Binding members for tenascin-c domain a2 |
| 07/23/2009 | WO2009089846A1 Methods for increasing the therapeutic efficacy of immunoglobulin g class 3 (igg3) antibodies |
| 07/23/2009 | WO2009058492A3 Fc variants with altered binding to fcrn |
| 07/23/2009 | WO2009052081A4 Antibodies that bind il-4 and/or il-13 and their uses |
| 07/23/2009 | WO2009050453A3 Breast cancer associated antigen |
| 07/23/2009 | WO2008142693A8 Regulation of myelination by nectin-like (necl) molecules |
| 07/23/2009 | WO2008136774A8 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide |
| 07/23/2009 | WO2008136736A8 Immunoregulatory structures from normally occurring proteins |
| 07/23/2009 | WO2008133684A8 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 07/23/2009 | WO2008052489A8 Recombinant antibodies against vascular endothelial growth factor (vegf) |
| 07/23/2009 | WO2007143701A8 Monoclonal antibodies that potently neutralize hepatitis c virus (hcv) of diverse genotypes |
| 07/23/2009 | WO2007106707A8 Identification and engineering of antibodies with variant heavy chains and methods of using same |
| 07/23/2009 | WO2007100248A4 Adir related polymorphisms and applications thereof |
| 07/23/2009 | WO2007092939A8 Antigenic gm-csf peptides and antibodies to gm-csf |
| 07/23/2009 | WO2007090294A8 Anti-bfa4 monoclonal antibodies and for cancer diagnostics and treatment |
| 07/23/2009 | WO2007084922A8 Compositions and methods for humanization and optimization of n-glycans in plants |
| 07/23/2009 | WO2004026891A3 Protein purification |
| 07/23/2009 | US20090188010 Insect Chymotrypsin and Inhibitors Thereof |
| 07/23/2009 | US20090188000 Gene family (lbfl313) associated with pancreatic cancer |
| 07/23/2009 | US20090187007 Using estrogen receptor specific immunoglobulins to treat cell proliferative disorders of mammary glands |
| 07/23/2009 | US20090186824 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/23/2009 | US20090186812 Apo-2 ligand |
| 07/23/2009 | US20090186409 Compositions and methods for the diagnosis and treatment of tumor |
| 07/23/2009 | US20090186376 sVEGFR-2 AND ITS ROLE IN LYMPHANGIOGENESIS MODULATION |
| 07/23/2009 | US20090186367 Diagnosis of fertility conditions using a serine protease |
| 07/23/2009 | US20090186363 Compositions and methods for the diagnosis and treatment of tumor |
| 07/23/2009 | US20090186355 Method for determination and quantification of radiation or genotoxin exposure |
| 07/23/2009 | US20090186338 Oligonucleotides originating from sequences coding for the surface component of ptlv envelope proteins and their uses |
| 07/23/2009 | US20090186075 Composition |
| 07/23/2009 | US20090186044 Type iv collagen-like immunoreactive peptide |
| 07/23/2009 | US20090186042 Identification and use of novopeptides for the treatment of cancer |
| 07/23/2009 | US20090186038 Methods of Preventing or Treating Respiratory Conditions |
| 07/23/2009 | US20090186037 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 07/23/2009 | US20090186036 Anti-Alpha V Beta 6 Antibodies |
| 07/23/2009 | US20090186033 Anti-amyloid immunogenic compositions, methods and uses |
| 07/23/2009 | US20090186032 Bio-Markers For Diagnosing Diabetic Retinopathy |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186029 Anticholesterol agents; generating an antibody which binds specifically to a C-terminal fragment of a vertebrate hedgehog polypeptide, comprising immunizing a mammalian subject with the C-terminal fragment |
| 07/23/2009 | US20090186027 Single chain antibodies against beta-amyloid peptide |
| 07/23/2009 | US20090186026 Ephrin and eph receptor agonists for modulation of bone formation and resorption |
| 07/23/2009 | US20090186025 Fusion Protein Comprising an Fc Receptor Binding Polypeptide and an Antigenic Polypeptide for Mediating an Immune Response |
| 07/23/2009 | US20090186023 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions |
| 07/23/2009 | US20090186022 Organic Compounds |
| 07/23/2009 | US20090186021 Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents |
| 07/23/2009 | US20090186020 Melanocortin Receptor Binding Mimetibodies, Compositions, Methods and Uses |
| 07/23/2009 | US20090186018 Compositions and methods for the treatment of rheumatoid arthritis |
| 07/23/2009 | US20090186008 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2009 | US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof |
| 07/23/2009 | US20090185978 Monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 07/23/2009 | US20090185974 Chimeric, Human and Humanized Anti-Granulocyte Antibodies and Methods of Use |
| 07/23/2009 | CA2712404A1 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders |
| 07/23/2009 | CA2712309A1 Composition and method for diagnosis or detection of renal cancer |
| 07/23/2009 | CA2712298A1 Improved anti-trkb antibodies |
| 07/23/2009 | CA2711962A1 Improved mammalian expression vectors and uses thereof |
| 07/23/2009 | CA2711938A1 Methods for manipulating phagocytosis mediated by cd47 |
| 07/23/2009 | CA2711763A1 Methods of treating bone-loss disorders using a gm-csf antagonist |
| 07/23/2009 | CA2710912A1 Afucosylated antibodies against ccr5 and their use |
| 07/23/2009 | CA2710619A1 Inhibiting angiogenesis using egfl8 antagonists |
| 07/23/2009 | CA2710439A1 Methods for increasing the therapeutic efficacy of immunoglobulin g class 3 (igg3) antibodies |
| 07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
| 07/22/2009 | EP2080802A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/22/2009 | EP2080770A1 Proteinaceous binding molecules comprising purification tags |
| 07/22/2009 | EP2080766A1 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2080520A1 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 07/22/2009 | EP2079840A1 Immunotox n fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
| 07/22/2009 | EP2079761A2 Prevention of aggregation of immunoglobulin light or heavy chains |
| 07/22/2009 | EP2079760A2 Compositions and methods for the treatment of infections and tumors |
| 07/22/2009 | EP2079759A2 Generation of heavy-chain only antibodies in transgenic animals |
| 07/22/2009 | EP2079484A2 Monitoring cancer stem cells |
| 07/22/2009 | EP2079482A2 Use of an anti-cd151 antibody in the treatment of cancer |
| 07/22/2009 | EP2006377A9 Novel tumor antigen peptides |
| 07/22/2009 | EP2006375A9 Panel cell used for granulocyte antibody detection |
| 07/22/2009 | EP1863846B1 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses |